PERLOCLENGENE PARVEC
UNII 5J5KE7G8TF

Substance Identification & Data

This profile provides standardized clinical and technical data for Perloclengene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5J5KE7G8TF.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3064385-67-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5J5KE7G8TF

CAS Registry Number

3064385-67-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PERLOCLENGENE PARVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13966

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Perloclengene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PERLOCLENGENE PARVEC

Common Names & Synonyms

PERLOCLENGENE PARVEC [INN]

RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 9 (RAAV9) VECTOR ENCODING CODON-OPTIMISED TRIPEPTIDYL-PEPTIDASE 1 (TPP1; LYSOSOMAL PEPSTATIN-INSENSITIVE PROTEASE, CLN2 (CEROID-LIPOFUSCINOSIS NEURONAL 2)) UNDER CONTROL OF A CYTOMEGALOVIRUS (CMV) IMMEDIATE-EARLY ENHANCER/CHICKEN .BETA.-ACTIN PROMOTER WITH TRANSCRIPTION ENHANCEMENT BY THE CHICKEN .BETA.-ACTIN INTRON, TERMINATED WITH A RABBIT .BETA.-GLOBIN (RBG) POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)

External Clinical & Regulatory Resources

Previous UNII5J5I9EB41E

Next UNII5J5OJ7GH15